A Half-Year After Legalization: Canopy Growth (TSX:WEED) vs. Aurora Cannabis (TSX:ACB)

The end of April marks over six months since Canada officially legalized recreational cannabis. It has not been the most efficient roll-out across the provinces, but production at the top producers is starting the ramp up. By the end of 2019, supply issues should be largely resolved. Now investors can worry about growth at the top companies. The sector has…

Read More

PSIQ Reports Record Breaking Annual Revenues of $ 876,448 for 2018 as Compared to $ 208,236 for 2017, an Increase of Over 400% and Poised for Rapid Expansion in 2019

Profile Solutions, Inc.

SUNRISE, Fla., April 04, 2019 (GLOBE NEWSWIRE) — Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), reported Revenues for the year ending December 31st 2018 of $876,448 compared to Revenues of $208,236 for the year ending December 31st 2017, representing an increase of over 400%. The financial statement can be…

Read More

Kali-Extracts Announces Developing Cannabis Pain Management Treatment For $83 Billion Market Specifically Targeting Cancer

Kali Extracts

DALLAS, April 04, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its ongoing research and development of a cannabis pain management treatment derived from the company’s patented cannabis extraction process. While cannabis for pain management treatment from cancer is not new, KALY is developing a proprietary extract that…

Read More

Could Aphria Inc (TSX:APHA) Beat Analyst Revenue Estimates in its Upcoming Earnings Report?

Leading Canadian marijuana firm Aphria (TSX:APHA)(NYSE:APHA) is set to release its fiscal third-quarter (Q3 2019) financial results for the period ended February 28 on April 15 before market open. Revenue growth and operating cost management remain the key investor focus right now and there is a strong chance that the company could surpass current analyst top-line projections in the upcoming…

Read More

Captor Sells its MedMen Branded Retail Operations to MedMen for USD$31,255,353


TORONTO, Feb. 04, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: NWURF), a cannabis-focused investment company, is pleased to announce that it has sold its two MedMen branded retail operations in southern California to MedMen for USD$31,255,353 pursuant to a stock purchase agreement entered into on January 9, 2019 (the…

Read More